• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年中的全民医保与避孕药具发放

Universal Pharmacare and Contraceptive Dispensations Among Youth.

作者信息

Downey Amanda K, Hanna Steven E, Levine Mitchell A, Schummers Laura, Guindon G Emmanuel

机构信息

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

St Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada.

出版信息

JAMA Pediatr. 2025 Aug 18. doi: 10.1001/jamapediatrics.2025.2585.

DOI:10.1001/jamapediatrics.2025.2585
PMID:40824678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12362276/
Abstract

IMPORTANCE

Previous studies have suggested that removing financial barriers to contraception could help reduce unintended pregnancy.

OBJECTIVE

To assess whether introduction of universal public funding for prescription contraception in Ontario (OHIP+) for individuals younger than 25 years and the amended program, which limited public funding to those without private insurance (OHIP-), is associated with changes in contraceptive dispensations.

DESIGN, SETTING, AND PARTICIPANTS: Interrupted time-series analyses were used to evaluate whether implementation of either policy was associated with changes in monthly contraceptives dispensed. The setting included a national database on contraceptives dispensed from retail pharmacies between September 2016 and February 2020; data analysis was performed from May 2022 to 2024. Participants included Ontario females aged 15 to 24 years to whom prescriptions were dispensed (intervention) vs controls: (1) Canadian females aged 15 to 24 years, excluding Ontario, and (2) Ontario females aged 25 to 49 years.

EXPOSURES

Implementation of free prescription contraception through OHIP+ (January 2018-March 2019) and OHIP- (April 2019-February 2020).

MAIN OUTCOMES AND MEASURES

Monthly dispensations of intrauterine devices (IUDs) and oral contraceptive pills (OCPs) per 1000 females overall and by area-level socioeconomic status (SES).

RESULTS

After OHIP+, there was an immediate level increase in IUDs dispensed to Ontario females aged 15 to 24 years (intervention) of 0.50 (95% CI, 0.15-0.84) vs 0.03 (95% CI, -0.26 to 0.32) in Canadian females aged 15 to 24 years-a relative increase of 0.48 (95% CI, 0.02-0.91). There was an immediate level increase in OCPs dispensed to Ontario females aged 15 to 24 years of 22.3 (95% CI, 14.8-29.8) vs 7.57 (95% CI, 3.07-12.1) in those aged 25 to 49 years-a relative increase of 14.8 (95% CI, 6.15-23.4). There were no statistically significant changes in monthly dispensation trends after OHIP+ and no statistically significant changes after OHIP-. In areas with lower SES, there was a significant increase in the level for IUDs of 0.64 (95% CI, 0.02-1.26) and for OCPs of 13.2 (95% CI, 1.33-25.0) after OHIP+, and a significant decrease in the level for IUDs of 0.82 (95% CI, -1.55 to -0.09) after OHIP- in Ontario vs Canadian females aged 15 to 24 years. No statistically significant changes in IUD or OCP dispensations were observed in areas with higher SES vs controls.

CONCLUSIONS AND RELEVANCE

Results reveal that providing comprehensive and confidential access to prescription contraceptives was associated with increased dispensations among Ontario youth.

摘要

重要性

先前的研究表明,消除避孕的经济障碍有助于减少意外怀孕。

目的

评估安大略省为25岁以下个人引入免费处方避孕公共资金(OHIP+)以及修订后的项目(该项目将公共资金限制在没有私人保险的人身上,即OHIP-)是否与避孕药具发放量的变化有关。

设计、背景和参与者:采用中断时间序列分析来评估这两项政策的实施是否与每月发放的避孕药具数量变化有关。背景包括一个2016年9月至2020年2月期间零售药店避孕药具发放情况的全国数据库;数据分析于2022年5月至2024年进行。参与者包括15至24岁获得处方的安大略省女性(干预组)与对照组:(1)15至24岁的加拿大女性(不包括安大略省),以及(2)25至49岁的安大略省女性。

暴露因素

通过OHIP+(2018年1月至2019年3月)和OHIP-(2019年4月至2020年2月)实施免费处方避孕。

主要结局和测量指标

每1000名女性每月宫内节育器(IUD)和口服避孕药(OCP)的发放量,以及按地区社会经济地位(SES)划分的发放量。

结果

在OHIP+实施后,15至24岁安大略省女性(干预组)IUD的发放量立即出现水平上升,为0.50(95%CI,0.15 - 0.84),而15至24岁加拿大女性为0.03(95%CI,-0.26至0.32)——相对增加0.48(95%CI,0.02 - 0.91)。15至24岁安大略省女性OCP的发放量立即出现水平上升,为22.3(95%CI,14.8 - 29.8),而25至49岁女性为7.57(95%CI,3.07 - 12.1)——相对增加14.8(95%CI,6.15 - 23.4)。OHIP+实施后每月发放趋势无统计学显著变化,OHIP-实施后也无统计学显著变化。在社会经济地位较低的地区,OHIP+实施后IUD发放量显著增加0.64(95%CI,0.02 - 1.26),OCP发放量显著增加13.2(95%CI,1.33 - 25.0);与15至24岁的加拿大女性相比,安大略省OHIP-实施后IUD发放量显著减少0.82(95%CI,-1.55至-0.0)。在社会经济地位较高的地区,与对照组相比,IUD或OCP发放量未观察到统计学显著变化。

结论及意义

结果表明,提供全面且保密的处方避孕药具获取途径与安大略省青少年中发放量增加有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/3efdda810001/jamapediatr-e252585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/470335bfc53b/jamapediatr-e252585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/a7a334bee654/jamapediatr-e252585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/a6338d6d9c99/jamapediatr-e252585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/3efdda810001/jamapediatr-e252585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/470335bfc53b/jamapediatr-e252585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/a7a334bee654/jamapediatr-e252585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/a6338d6d9c99/jamapediatr-e252585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/12362276/3efdda810001/jamapediatr-e252585-g004.jpg

相似文献

1
Universal Pharmacare and Contraceptive Dispensations Among Youth.青少年中的全民医保与避孕药具发放
JAMA Pediatr. 2025 Aug 18. doi: 10.1001/jamapediatrics.2025.2585.
2
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.即刻与产后延迟放置避孕埋植剂和宫内节育器避孕效果比较。
Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Trends in Abortion Rates in Ontario, Canada.加拿大安大略省的堕胎率趋势。
JAMA Netw Open. 2025 Apr 1;8(4):e254516. doi: 10.1001/jamanetworkopen.2025.4516.
5
Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.全民免费覆盖对长效可逆避孕法及所有处方避孕法使用情况的影响:基于人群的对照中断时间序列分析
BMJ. 2025 Jul 28;390:e083874. doi: 10.1136/bmj-2024-083874.
6
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.激素浸渍宫内节育系统(IUSs)与其他形式的可逆性避孕方法作为预防妊娠的有效方法。
Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2.
7
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
8
Combined oral contraceptive pill for primary dysmenorrhoea.复方口服避孕药治疗原发性痛经。
Cochrane Database Syst Rev. 2023 Jul 31;7(7):CD002120. doi: 10.1002/14651858.CD002120.pub4.
9
Immediate postabortal insertion of intrauterine devices.流产后立即放置宫内节育器。
Cochrane Database Syst Rev. 2002(3):CD001777. doi: 10.1002/14651858.CD001777.
10
Interventions for emergency contraception.紧急避孕的干预措施。
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324. doi: 10.1002/14651858.CD001324.pub5.

本文引用的文献

1
Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment.一项公共资助的药物福利计划政策对儿童和青少年苯二氮䓬类药物配药的影响:一项基于人群的自然实验。
BMC Pediatr. 2023 Oct 19;23(1):519. doi: 10.1186/s12887-023-04331-4.
2
Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment.公共资助的药品计划对儿童和青少年处方兴奋剂使用的影响:基于人群的观察性自然实验。
Can J Psychiatry. 2023 Nov;68(11):826-837. doi: 10.1177/07067437231166836. Epub 2023 Apr 5.
3
The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies.
《处方药品保险和费用分担与药物使用、卫生服务使用和健康的关联:加拿大研究的系统评价》。
Value Health. 2023 Jul;26(7):1107-1129. doi: 10.1016/j.jval.2023.02.010. Epub 2023 Feb 24.
4
The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis.安大略省 OHIP+ 药品福利计划对儿童和青少年公共药品计划使用和成本的影响:时间序列分析。
CMAJ Open. 2022 Sep 27;10(3):E848-E855. doi: 10.9778/cmajo.20210295. Print 2022 Sep-Oct.
5
Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada.加拿大直接作用抗病毒药物(DAA)的公共支付与私人支付比较。
Can Liver J. 2021 Nov 11;4(4):426-429. doi: 10.3138/canlivj-2020-0041. eCollection 2021 Fall.
6
Use of reproductive health services among women using long- or short-acting contraceptive methods - a register-based cohort study from Finland.长效或短效避孕方法使用者中的生殖健康服务利用情况——一项来自芬兰的基于登记的队列研究。
BMC Public Health. 2022 Jun 14;22(1):1185. doi: 10.1186/s12889-022-13581-3.
7
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis.加拿大安大略省全民医保覆盖对 1 型糖尿病患儿血糖管理的影响及其与社会经济差异的关系:基于人群的趋势分析。
CMAJ Open. 2022 Jun 14;10(2):E519-E526. doi: 10.9778/cmajo.20210214. Print 2022 Apr-Jun.
8
A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.系统综述 umbrella review 处方药保险与费用分担与药物使用、卫生服务使用和健康的关联。
BMC Health Serv Res. 2022 Mar 3;22(1):297. doi: 10.1186/s12913-022-07554-w.
9
Variability in prescription medication coverage for children and youth across Canada: A scoping review.加拿大儿童和青少年处方药覆盖范围的变异性:范围综述。
Health Policy. 2022 Mar;126(3):269-279. doi: 10.1016/j.healthpol.2022.01.012. Epub 2022 Jan 25.
10
Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study.缬沙坦药物短缺的程度及其对加拿大人群中抗高血压药物使用的影响:一项全国性的横断面研究。
CMAJ Open. 2021 Dec 7;9(4):E1128-E1133. doi: 10.9778/cmajo.20200232. Print 2021 Oct-Dec.